The fines and penalties imposed on companies, their management and their directors for anticompetitive practices are expected to increase so it is vital that companies ensure they are not breaching competition laws, says Ángel Valdé
Ruling means exclusivity rebates will not always be considered an abuse of dominance, while banking enquiry means increasing focus on sophisticated financial products
There is considerable demand from pharmaceutical and biotechnology companies for EU and competition law advice due to continuous changes to regulations, says Ricardo Rodrigues Lopes, partner at Caiado Guerreiro.
